Immunotherapy and gene therapy in prostate cancer treatment

Area of Science:

• Oncology
• Immunotherapy
• Cellular Therapy

Background:

• Prostate cancer remains a significant health concern with evolving treatment landscapes.
• Traditional therapies have limitations in efficacy and side effect profiles for certain patient groups.
• Recent therapeutic strategies focus on personalized approaches for improved outcomes.

Purpose of the Study:

• To review recent advances in cell-based personalized therapies for prostate cancer.
• To highlight the mechanisms of action for these novel treatment modalities.
• To discuss the potential impact on patient survival and tumor progression.

Main Methods:

• Review of recent scientific literature on advanced prostate cancer therapies.
• Analysis of studies employing patient-derived cells (normal or pathological) for therapeutic purposes.
• Evaluation of treatment protocols involving cell modification and autologous reintroduction.

Main Results:

• Personalized cell therapies demonstrate increased efficiency against neoplastic prostate cancer tissue.
• These advanced treatments show potential for extending patient lifespan.
• Evidence suggests a positive impact on delaying or halting tumor progression.

Conclusions:

• Cell-based personalized therapies represent a promising frontier in prostate cancer treatment.
• These approaches offer enhanced efficacy by targeting cancer cells more specifically.
• Further research and clinical application are warranted to optimize patient outcomes.